Literature DB >> 31742564

Low vitamin D is associated with coronary atherosclerosis in women with HIV.

Lediya T Cheru1, Charles F Saylor1, Kathleen V Fitch1, Sara E Looby1,2, Michael Lu3, Udo Hoffmann3, Takara L Stanley1, Janet Lo1.   

Abstract

BACKGROUND: Vitamin D deficiency is underdiagnosed and undertreated, especially among people living with HIV (PLWH). Recently, there has been an increased interest in the role of vitamin D in cardiovascular disease (CVD). While vitamin D deficiency has been associated with CVD in observational studies in the general population, there are limited data in PLWH. We therefore performed an analysis to assess the relationship of vitamin D and coronary atherosclerosis using coronary CT angiography (CCTA).
METHODS: Women living with HIV (WLWH) without known CVD were included. Based on the median value of serum vitamin D levels, participants were dichotomized to either the <25 ng/ml (lower vitamin D group) or ≥25 ng/ml (higher vitamin D group). CCTA was used to assess plaque characteristics.
RESULTS: Forty-three WLWH were included in the analyses (mean age 46 ±8 years, 56% African American, duration of HIV 15 ±6 years, 83% undetectable HIV viral load). WLWH in the lower vitamin D group (n=22) had significantly higher numbers of segments with any coronary plaque (2.27 ±3.01 versus 0.38 ±0.97; P=0.02) and segments with non-calcified coronary plaque (1.41 ±1.82 versus 0.29 ±0.64; P=0.03) compared with WLWH in the higher vitamin D group (n=21). After adjusting for Framingham CHD risk point score, body mass index, diabetes and race, the relationship remained significant.
CONCLUSIONS: Our study demonstrates a significant, independent relationship between lower vitamin D status and higher numbers of noncalcified coronary plaque segments in WLWH. Further studies are warranted to evaluate the effect of vitamin D on CVD in PLWH. Trial Registration Identifier: NCT00455793.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31742564      PMCID: PMC7882065          DOI: 10.3851/IMP3336

Source DB:  PubMed          Journal:  Antivir Ther        ISSN: 1359-6535


  38 in total

Review 1.  Cardiovascular risk and body-fat abnormalities in HIV-infected adults.

Authors:  Steven Grinspoon; Andrew Carr
Journal:  N Engl J Med       Date:  2005-01-06       Impact factor: 91.245

2.  Vitamin D deficiency and electrocardiographic subclinical myocardial injury: Results from National Health and Nutrition Examination Survey-III.

Authors:  Muhammad I Ahmad; Parag A Chevli; Yabing Li; Elsayed Z Soliman
Journal:  Clin Cardiol       Date:  2018-11-20       Impact factor: 2.882

3.  Isolated vitamin D supplementation improves the immune-inflammatory biomarkers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.

Authors:  Flavia Neves Bueloni-Dias; Claudio Lera Orsatti; Luciana Mendes Cangussu; Priscila Ferreira Poloni; Daniel Spadoto-Dias; Jorge Nahas-Neto; Eliana A P Nahas
Journal:  Menopause       Date:  2018-08       Impact factor: 2.953

4.  Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

Authors:  Janet Lo; Suhny Abbara; Leon Shturman; Anand Soni; Jeffrey Wei; Jose A Rocha-Filho; Khurram Nasir; Steven K Grinspoon
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

5.  Impact of 1,25(OH) 2 D 3 on TG content in liver of rats with type 2 diabetes.

Authors:  Yan Yang; Beibei Liu; Ling Gao; Qi Li; He Wang; Liandi Wang
Journal:  Acta Cir Bras       Date:  2018-06       Impact factor: 1.388

6.  Effect of vitamin D intake on seasonal variations in parathyroid hormone secretion in postmenopausal women.

Authors:  E A Krall; N Sahyoun; S Tannenbaum; G E Dallal; B Dawson-Hughes
Journal:  N Engl J Med       Date:  1989-12-28       Impact factor: 91.245

7.  HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D.

Authors:  Mario Cozzolino; Marcos Vidal; Maria Vittoria Arcidiacono; Pablo Tebas; Kevin E Yarasheski; Adriana S Dusso
Journal:  AIDS       Date:  2003-03-07       Impact factor: 4.177

8.  NOVEL MECHANISMS AND ANTI-INFLAMMATORY STRATEGIES TO REDUCE CARDIOVASCULAR RISK IN HUMAN IMMUNODEFICIENCY VIRUS.

Authors:  Steven Grinspoon
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

9.  Assessment of Subclinical Atherosclerosis in Vitamin D Deficiency.

Authors:  Elçin Aydin; Cihan Altin; Gözde Özcan Söylev; Mustafa Agah Tekindal; Muhteşem Ağildere
Journal:  Ultrasound Q       Date:  2019-06       Impact factor: 1.657

Review 10.  The nuclear receptor superfamily: the second decade.

Authors:  D J Mangelsdorf; C Thummel; M Beato; P Herrlich; G Schütz; K Umesono; B Blumberg; P Kastner; M Mark; P Chambon; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

View more
  3 in total

1.  Cumulative HIV Viremia Copy-Years and Hypertension in People Living with HIV.

Authors:  Yunan Xu; Xinguang Chen; Akemi Wijayabahu; Zhi Zhou; Bin Yu; Emma C Spencer; Robert L Cook
Journal:  Curr HIV Res       Date:  2020       Impact factor: 1.581

Review 2.  Serum biomarkers for arterial calcification in humans: A systematic review.

Authors:  Nienke M S Golüke; Marit A Schoffelmeer; Annemarieke De Jonghe; Mariëlle H Emmelot-Vonk; Pim A De Jong; Huiberdina L Koek
Journal:  Bone Rep       Date:  2022-06-18

3.  Prevalence and Predictors of Hypovitaminosis D in Ethiopian HIV-Infected Adults.

Authors:  Abebe Muche Belete; Alemu Adela Tefera; Mekasha Getnet; Adisu Asefa; Yared Asmare Aynalem; Wondimeneh Shibabaw Shiferaw
Journal:  HIV AIDS (Auckl)       Date:  2021-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.